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2Abstract
Ethnopharmacological relevance: Oxidative stress is a prominent feature of 
clinical acute pancreatitis (AP). Coreopsis tinctoria has been used traditionally 
to treat pancreas disorders like diabetes mellitus in China and Portugal and its 
flavonoid-rich fraction contain the main phytochemicals that have antioxidant 
and anti-inflammatory activities. 
Aim of the study: To investigate the effects of flavonoids isolated from C. 
tinctoria on experimental AP and explore the potential mechanism.  
Material and methods: LC-MS based online technique was used to analyse 
and isolate targeted flavonoids from C. tinctoria. Freshly isolated mouse 
pancreatic acinar cells were treated with taurocholic acid sodium salt hydrate 
(NaT, 5 mM) with or without flavonoids. Fluorescence microscopy and a plate 
reader were used to determine necrotic cell death pathway activation 
(propidium iodide), reactive oxygen species (ROS) production (H2-DCFDA) 
and ATP depletion (luminescence) where appropriate. AP was induced by 7 
repeated intraperitoneal caerulein injections (50 μg/kg) at hourly interval in mice 
or retrograde infusion of taurolithocholic acid 3-sulfate disodium salt (TLCS; 5 
mM, 50 μL) into the pancreatic duct in mice or infusion of NaT (3.5%, 1 mL/kg) 
in rats. A flavonoid was intraperitoneally administered at 0, 4, and 8 hours after 
the first caerulein injection or post-operation. Disease severity, oxidative stress 
and antioxidant markers were determined. 
3Results: Total flavonoids extract and flavonoids 1-6 (C1-C6) exhibited different 
capacities in reducing necrotic cell death pathway activation with 0.5 mM C1, 
(2R,3R)-taxifolin 7-O-β-D-glucopyranoside, having the best effect. C1 also 
significantly reduced NaT-induced ROS production and ATP depletion. C1 at 
12.5 mg/kg and 8.7 mg/kg (equivalent to 12.5 mg/kg for mice) significantly 
reduced histopathological, biochemical and immunological parameters in the 
caerulein-, TLCS- and NaT-induced AP models, respectively. C1 administration 
increased pancreatic nuclear factor erythroid 2-related factor 2 (Nrf2) and Nrf2-
medicated haeme oxygenase-1 expression and elevated pancreatic antioxidant 
enzymes superoxide dismutase and glutathione peroxidase levels. 
Conclusions: Flavonoid C1 from C. tinctoria was protective in experimental AP 
and this effect may at least in part be attributed to its antioxidant effects by 
activation of Nrf2-mediated pathways. These results suggest the potential 
utilisation of C. tinctoria to treat AP. 
Keywords: Coreopsis tinctoria; flavonoids; acute pancreatitis; oxidative stress; 
Nrf2; antioxidant enzymes. 
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oxygen species; SOD, superoxide dismutase; TFE, total flavonoids extraction; 
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51. Introduction
Acute pancreatitis (AP) is the commonest pancreatic disease and one of the 
most common digestive diseases that require emergency hospital admission, 
with a global increase of incidence (Forsmark et al., 2016; Peery et al., 2015; 
Xiao et al., 2016). While AP in patients with mild attacks is always considered 
to be uneventful, moderate to severe cases are often associated with significant 
compilations that may require surgical intervention and/or organ support (Banks 
et al., 2013). Despite recent advances in understanding of the pathogenesis 
and improvement of the management of AP (van Dijk et al., 2017), there is still 
no specific pharmacological therapy (Moggia et al., 2017).   
The important role of oxidative stress in the pathogenesis and progression of 
various of diseases including AP is well established (Leung and Chan, 2009). 
Increased oxidative stress includes an array of intermediates such as reactive 
oxygen species (ROS) and reactive nitrogen species that have been observed 
in bile acid-, ductal ligation-, caerulein- and amino acid-induced AP animal 
models (Leung and Chan, 2009). In parallel, pancreatic and serum levels of 
antioxidant-scavenging enzymes such as glutathione peroxidase (GPx), 
superoxide dismutase (SOD) and catalase are reduced (Leung and Chan, 
2009). The oxidative intermediates cause mitochondrial membrane 
depolarisation, lipid peroxidation, protein modification and DNA fragmentation 
in pancreatic acinar cells, leading to ATP deletion and necrosis (Booth et al., 
62011a; Hackert and Werner, 2011); they also switch on proinflammatory 
signalling pathways by involving mitogen-activated protein kinases, nuclear 
factor kappa B (NF-kB) and activator protein-1, all of which are key mediators 
of the inflammatory cascade during AP (Huang et al., 2016; Leung and Chan, 
2009).  
The nuclear factor erythroid 2–related factor 2 (Nrf2), a member of NF-E2 family 
of nuclear basic leucine zipper transcription factors, induces activation of 
antioxidant response elements (AREs) that regulate gene expression of a 
number of enzymes including GPx, SOD and haeme oxygenase-1 (HO-1) that 
detoxify oxidative intermediates (Hybertson et al., 2011; Ma, 2013). Under 
normal conditions, Nrf2 is constitutively degraded by its suppressor Kelch-like 
ECH-associated protein 1 (Keap1), which binds to the Nrf2 inhibitory Neh2 
domain in the cytosol (Ma, 2013). Under stress conditions, Keap1 is degraded 
to release Nrf2 that translocates into the nucleus, allowing the activation of 
AREs thus to execute its antioxidant defence function (Ma, 2013). Nrf2 
suppression in both the pancreas (Dong et al., 2016; Jung et al., 2010; Robles 
et al., 2016) and lung (Wang et al., 2014; Yu et al., 2016) has been implicated 
in murine AP models and correlates with disease severity, while its 
pharmacological activation reduces disease severity (Dong et al., 2016; Robles 
et al., 2016).  
A large number of compounds of plant origin including polyphenols, terpenes, 
7glycosides, quinones and flavonoids have been explored for treating a variety 
of pancreatic disorders including diabetes mellitus (DM) and AP (Anchi et al., 
2017). Flavonoids are richly available in large number of vegetables, fruits, tea 
and herb and the protective mechanisms against AP at least involve antioxidant 
and anti-inflammatory properties acting on Nrf2 and NF-kB pathways (Shapiro 
et al., 2007). Coreopsis tinctoria Nutt (Asteraceae; also called snow 
chrysanthemum) is a plant native to North America that has spread worldwide. 
It has been used to treat several diseases including DM, diarrhoea and internal 
pain in North America, Portugal and China (Dias et al., 2010; Foster and Duke, 
1990; Cui and Ran, 1993; D’Oliveira Feijão R., 1973). Recently, it has been 
reported that C. tinctoria has antidiabetic (Dias et al., 2010) and antioxidant 
(Chen et al., 2016; Wang et al., 2015) activities that have been attributed to its 
flavonoid components. As we all known, both AP and diabetes are pancreatic 
disorder related disease. Emerging evidence suggests that insulin protects 
against pancreatic toxin-induced acinar cell injury. (Samad et al., 2014) In 
parallel, flavonoids from C. tinctoria could improve insulin sensitivity. (Jiang et 
al., 2015.) These suggest flavonoids from C. tinctoria might be used to target 
AP.
The aim of this study was to investigate the potential protective effects of 
leading flavonoids isolated from C. tinctoria against AP in vitro and in vivo. We 
first used an LC-MS based online technique to analyse and isolate targeted 
flavonoids. Then we tested these flavonoids on necrotic cell death activation in 
8freshly isolated acinar cells and further applied them to three different murine 
AP models. Lastly, we examined whether the protective effects of C. tinctoria 
was at least in part via modulation of Nrf2/ARE-mediated antioxidant signalling 
pathways. 
92. Materials and methods
2.1. Animals and reagents
Male Balb/C mice (25–30 g) and male Wistar rats (250–300 g) were purchased 
from Chengdu Dossy Experimental Animals Co. LTD (Sichuan, China). Male 
C57/BL6J mice (25–30 g) were purchased from Beijing Huafukang Bioscience 
Co. LTD (Beijing, China). Animals were maintained at 22 ± 2°C and exposed to 
a 12 h light-dark cycle, fed with standard laboratory chow and water, allowed to 
acclimatise for a minimum of one week. Animals were fasted for 12 h before 
induction of AP and food was resumed 1 hour after the initial procedure. All 
animal experiments were approved by the Ethics Committee of West China 
Hospital of Sichuan University (2017065A). 
Acetonitrile and methanol (MeOH) were from Fisher Scientific (Pittsburgh, PA, 
USA). Hoechest33342, propidium iodide (PI) and 2,7-dichlorodi-
hydrofluorescein diacetate (H2-DCFDA) were from Molecular Probes (Eugene, 
Oregon, USA). Caerulein and taurolithocholic acid 3-sulfate disodium salt 
(TLCS) were from Sigma-Aldrich (St. Louis, MO, USA). Antibodies against Nrf2 
and HO-1 were from Abcam (Cambridge, ΜΑ, USA). Antibody against NF-κB 
p65 was from Cell Signalling Technology (Danvers, MA, USA). Commercial kits 
for GPx and SOD were purchased from Nanjing Jiancheng Bioengineering 
Institute (Nanjing, Jiangsu, China). Interleukin-6 (IL-6) ELISA kit was from 
Abcam (Cambridge, UK). If not otherwise stated, all the other chemical 
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reagents were purchased from J&K with highest analytical grade (Beijing, 
China). 
2.2. Isolation and analysis of flavonoids from C. tinctoria
The capitula of C. tinctoria were from the research base of Uighur Autonomous 
Region Institute of Medicinal Plants (Xinjiang, China). A voucher specimen (No. 
201209) was preserved in the herbarium of Laboratory of Ethnopharmacology 
of West China Hospital, Sichuan University. The simplified procedure of 
isolating total flavonoids extraction (TFE) and compounds 1-6 is described in 
Supplementary Figure S-1. The dried capitula (5 kg) of C. tinctoria were 
extracted with 95% ethanol (EtOH) (3 times). After removal of the solvent under 
reduced pressure at 45°C, the residue (580 g) was directly subjected to 
polyamide resin column chromatograph, eluting with H2O, 35% EtOH and 65% 
EtOH, successively. The fraction (60.5 g) eluted with 35% EtOH was subjected 
to a Sephadex LH-20 column, eluting with MeOH to afford four fractions. TFE 
was mainly from Fr.3. It was further subjected to Sephadex LH-20, eluting with 
50% MeOH to afford six fractions. Fr. 3-2 was purified by prep. HPLC (10% 
acetonitrile, 280 nm) to yield compound 1 (C1, 320 mg). Fr. 3-6 purified by prep. 
HPLC (20% acetonitrile, 280 nm) to yield compounds 2 (C2, 260 mg), 3 (C3, 
330 mg), 4 (C4, 85 mg), 5 (C5, 228 mg), and 6 (C6, 370 mg).
The TFE was analysed on a UPLC I-Class (Waters ACQUITY, Miford, USA) 
coupled with a QTOF (Xevo G2-XS, Waters, Miford, USA). The separation was 
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performed on a HSS T3 column (2.1 × 100 mm, 1.8 μm) at 45°C. Gradient 
elution of 0.1% formic acid solution (Solvent A) and 0.1% formic acid acetonitrile 
solution (Solvent B) at a flow rate of 0.5 mL/min was employed: 0-0.2 min, 1% 
B; 0.2-8 min, 1-40% B; 8-12 min, 40-99% B; 12-14 min, 99% B; 14-16 min, 99-1% 
B. The injection volume was 1 μL. The Q-Tof system was operated on an 
electrospray ion source in negative ion mode. The mass range was set at m/z 
50-1200. The capillary voltage was 3.0 KV. The source temperature was 120°C, 
and desolvation temperature was 350 °C. Cone gas flow and desolvation gas 
flow were 50 and 800 L/Hr. The data were acquired on MSE mode, and 
analysed using a UNIFI 1.8 software.
2.3. Necrosis, ROS and ATP assays 
Pancreatic acinar cells were isolated freshly from Balb/c or C57/BL6J mice 
using a collagenase IV (Worthington Biochemical Corporation, Lakewood, NJ, 
USA) digestion procedure as previously described (Huang et al., 2014). Cells 
were treated under room temperature, and used within 4 hours after isolation. 
Cells were treated with 5 mM taurocholic acid sodium salt hydrate (NaT) with 
or without different extracts (1 mM) or various concentrations of C1 for 30 min, 
gently shaken at 50 rpm at room temperature to assess necrotic cell death 
pathway activation. The cells were washed and then stained with Hoechst 
33342 (50 µg/ml) and PI (1 µM). Images were taken by fluorescence 
microscopy ZEISS AX10 imager A2/AX10 cam HRC (Jena GmbH, Germany). 
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Data were calculated as PI stained cells divided by Hoechst 33342 stained cells 
and multiplied by 100%.
The cells were first incubated with a ROS indicator H2-DCFDA (Booth et al., 
2011b) for 20 min at 37°C in the dark. Then they were distributed into a 96-well 
glass black plates. The fluorescence was recorded on a Synergy Mx 
multifunctional Microplate Reader (Gene Company Ltd, Hong Kong, China) for 
30 min in total: the baseline was recorded for the first 5 min; after adding 0.5 
mM of C1, the fluorescence values were recorded for a second 5 min; after 
adding 5 mM of NaT, the fluorescence values were recorded for the last 20 min. 
The data of ROS quantification were expressed as F/F0 and quantified as the 
ΔF/F0 at 2250 s for all the groups. 
In separate experiments, 5 mM of NaT was added to the acinar cells with and 
without 0.5 mM of C1. After 20 and 40 minutes, the cells were re-suspended in 
a lysis buffer, boiled for 2 min, and centrifuged at 12,000 g for 5 min. The 
luminescence of the supernatant of each sample was measured by the 
Microplate Reader. The data were normalised to protein concentration counted 
by bicinchoninic acid protein (BCA) assay (Thermo Fisher Scientific, Waltham, 
MA, USA). 
2.4. Induction of AP models and administration of C1
Three AP models were used: (1) mice received seven intraperitoneal injections 
of a cholecystokinin analog caerulein (Saluja et al., 2007) at hourly interval to 
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induce hyperstimulation AP (CER-AP) (Huang et al., 2017a; Mukherjee et al., 
2016; Wen et al., 2015); (2) mice received retrograde pancreatic ductal injection 
of 5 mM TLCS (50 µL) to induced biliary AP (TLCS-AP) (Perides et al., 2010); 
(3) rats received retrograde pancreatic ductal injection of 3.5% NaT (1mL/kg) 
to induce biliary AP (NaT-AP) (Wan et al., 2012). 
Control mice received equivalent volume saline injections, while control mice or 
rats received sham operation without perfusion of TLCS or NaT. In the CER-
AP, C1 (12.5, 25, and 50 mg/kg) was administered at 0, 4, and 8 hours after 
the first injection of caerulein and mice in all groups were sacrificed at 12 hours; 
in the TLCS-AP and NaT-AP, C1 of 12.5 mg/kg or 8.7 mg/kg (equivalent to 12.5 
mg/kg in the mice) was administered at 0, 4, and 8 hours post-operation and all 
animals were sacrificed at 24 hours. Pancreas, lung and blood samples were 
collected for disease severity assessment and mechanistic study.   
2.5. Histopathology and immunohistochemistry (IHC) 
Pancreas samples were fixed in 10% buffered formaldehyde embedded in 
paraffin, sectioned in 5 mm and stained with haematoxylin and eosin (H&E). 
Pancreatic histopathology (magnification × 200) were scored independently by 
two pathologists who were unware of the study design. Criteria were oedema, 
inflammatory cell infiltration and necrosis with each component having a score 
of 0 to 3 as previously described (Wildi et al., 2007). For assessing pancreatic 
histopathology in the TLCS-AP, a 4-point scoring system for each component 
14
(oedema, inflammatory cell infiltration and necrosis) was used without scoring 
haemorrhage (Zhou and Xue, 2009). Immunostaining was performed on 4 µm-
thick sections after deparaffinisation. Microwave antigen retrieval was 
performed in citrate buffer (pH 6.0) for 10 min prior to peroxidase quenching 
with 3% H2O2 in MeOH for 10 min. Sections were then washed in water and 
preblocked with normal goat serum for 10 min. In the primary antibody reaction, 
slides were incubated for 1 hour at room temperature in a 1:100 dilution of 
antibody. The sections were then incubated with biotinylated secondary 
antibodies (1:1000) for 1 hour. Following a washing step with phosphate-
buffered saline, streptavidin-horseradish peroxidase (HRP) was applied. Finally, 
the sections were developed with diaminobenzidine tetrahydrochloride 
substrate for 5 min, and counterstained with hematoxylin. Each section was 
scanned using NanoZoomer 2.0 HT from HAMAMATSU Photonics 
(Hamamatsu, Japan), and analysed by Image-Pro Plus 6.0 (Rockville, MD, 
USA).
2.6. Measurement of trypsin and myeloperoxidase (MPO) activity
The detailed methodology of measuring trypsin and MPO activity was described 
as previously (Huang et al., 2017a; Huang et al., 2017b).    
2.7. Determination of serum amylase, lipase and IL-6 levels 
Serum amylase and lipase were measured using a full automatic biochemical 
analyser (Roche, Mannheim, Germany). IL-6 levels were evaluated by an 
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ELISA kit according to the manufacturer’s instructions.
2.8. Determination of pancreatic GPx and SOD levels 
Pancreatic GPx and SOD levels in homogenised pancreas tissue were 
measured using commercial kits as described (Dong et al., 2016). 
2.9. Western-blot analysis
The pancreatic tissue was pulverised after being snap-frozen in liquid nitrogen. 
Total protein was extracted by adding a cocktail (phosphate inhibitor, 
phenylmethylsulfonyl fluoride and protease inhibitor) at the proportion of 1 μg 
tissue per 10 μL cocktail. Total protein concentration was quantified using a 
BCA kit. A 30 μg aliquot of protein or equal proportion of concentrated 
supernatant was subjected to sodium dodecyl sulphate/polyacrylamide gel 
electrophoresis (Bio-Rad, CA, USA) and transferred to 
nitrocellulose/polyvinylidene fluoride membrane following the standard method. 
Membranes were blocked with 5% non-fat milk at room temperature for 1 hour 
and were further incubated overnight at 4°C with primary antibodies. β-actin 
was used as the internal reference for proteins. Membranes were washed with 
a mixture of tris-buffered saline and polysorbate 20 and incubated with a 
secondary goat anti-rabbit IgG-HRP antibody (1:5000) or goat anti-mouse IgG-
HRP antibody (1:10000) (Proteintech, Wuhan, Hubei, China) for 1 hour at room 
temperature. Finally, membranes were washed and developed using the 
detection system (Bio-Rad, Hercules, CA, USA).
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2.10. Statistical analysis
Statistical analysis was performed using ANOVA and an unpaired Student’s t-
test. A P-value of < 0.05 was taken to indicate statistical signiﬁcance. Statistical 
calculations were performed using SPSS software for Windows (Version 21.0; 
SPSS, Chicago, IL, USA).
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3. Results 
3.1. LC/MS analysis of TFE from C. tinctoria and identification of the C1 - 
C6
The TFE was purified from EtOH extract of C. tinctoria by multiple column 
chromatography. The TFE was first detected under the negative mode by 
UPLC-QTof/MS (Figure 1). The peaks in the base peak intensity (BPI) 
chromatograph of TFE were identified as 19 flavonoids by comparing MS data 
with data base, the components were listed in Supplementary Table S-1. 
Thereof, peaks 1-6 were targetedly isolated from the TFE, and determined to 
be (2R,3R)-taxifolin 7-O-β-D-glucopyranoside (C1), (2S)-flavanomarein (C2), 
(2S)-eriodictyol 7-O-β-D-glucopyranoside (C3), (2S)-flavanocorepsin (C4), 
maritimein (C5) and marein (C6) by comparisons with references. 
(Supplementary Figures S2-7)
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Fig. 1. Representative base peak intensity (BPI) chromatogram of total 
flavonoids extract (TFE) isolated from C. tinctoria and structures of compounds 
1-6 (C1-C6) isolated from TFE. (A) BPI chromatograms were monitored in 
negative ion mode. (B) C1-C6 were identified as (2R,3R)-taxifolin 7-O-β-D-
glucopyranoside (C1), (2S)-flavanomarein (C2), (2S)-eriodictyol 7-O-β-D-
glucopyranoside (C3), (2S)-flavanocorepsin (C4), maritimein (C5) and marein 
(C6).
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3.2. C1 showed the strongest protective effect in reducing necrotic cell 
death pathway activation 
The effects of extracts (1 mM) prior to TFE on necrotic cell death pathway 
activation in acinar cells induced by NaT (5 mM) are shown in Supplementary 
Figures S-8, while the effects of TFE and C1-C6 (1 mM) are shown in Figure 
2A. The control cells had a baseline PI uptake around 20%, this was 
dramatically increased after the application of 5 mM NaT (normalised to 100%). 
NaT-induced PI uptake was reduced in total extract and 3 out of 4 extracts from 
the 35% EtOH extract, but not H2O extract or 65% EtOH extract. NaT-induced 
PI uptake was reduced to below 50% by C1-C4 with the best effect achieved 
by C1 (28%), while no significant alterations were observed by TFE or C5; there 
was a trend towards a reduction by C6, but this did not reach statistical 
significance. We further explored the effects of different concentrations (0.25, 
0.5 and 1 mM) of C1, a flavanonol, on necrotic cell death pathway activation 
(Figure 2B). While a more reduced PI uptake was observed at 0.5 mM, there 
was no significant difference among different concentration used. 
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Fig. 2. Effects of flavonoids isolated from C. tinctoria on necrotic cell death 
activation in mouse pancreatic acinar cells. Cells were treated with normal 
saline or taurocholic acid sodium salt hydrate (NaT, 5 mM) with or without 
compounds at designated concentrations. The necrosis % (PI uptake) induced 
by NaT was calculated from Hoechst 33342 stained cells and multiply by 100 %. 
(A) Effects of TFE and C1-C6 at the concentration of 1 mM. (B) Effects of C1 
at the concentration of 0.25, 0.5 and 1 mM. (C) Representative images showing 
Hoechst 33342 (blue) and PI (red) stained with cells treated with normal saline, 
NaT, and NaT + C1 (0.5 mM). Data are expressed as mean ± SEM from 3 or 
more independent experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. model 
group, ###P < 0.001 vs. control group. In the histogram: dark grey = control, 
black = NaT, and white = NaT with treatment (TFE or C1-C6). 
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3.3. C1 reduced ROS production and ATP depletion 
The inhibitory effects of C1 on ROS production by NaT (5 mM) were 
investigated (Figure 3A(i)). There was a sustained increase of ROS reflected 
by fluorescence intensity of H2-DCFDA followed stimulation with NaT (1.41), 
which was reduced to 1.13 by C1 application, and the absolute difference was 
significant (0.38 vs. 0.11, P < 0.001; Figure 3A(ii)). In line with this, NaT induced 
marked ATP depletion at 20 and 40 mins; these were significantly reverted by 
application of C1 (48% vs. 64% at 20 mins; 18% vs. 26% at 40 mins; both P < 
0.001; Figure 3B). These data collectively suggest that the protective effects of 
C1 on necrotic cell death pathway in acinar cells at least in part were mediated 
by inhibition of ROS production to preserve ATP levels.  
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Fig. 3. Effects of C1 on ROS production and ATP depletion in mouse pancreatic 
acinar cells. Cells were treated with normal saline or taurocholic acid sodium 
salt hydrate (NaT, 5 mM) with or without C1 (0.5 mM). ROS was measured by 
fluorescent H2-DCFDA and ATP was tested by luminescence. (A) Typical 
traces NaT-induced ROS production which was suppressed by C1 
administration. (B) Summary quantification of ROS production. (C) The 
inhibition effect of C1 on ATP deletion. Data are normalised to the control as 
100%. Data are expressed as the means ± SEM from 3 or more independent 
experiments. ***P < 0.001 vs. NaT group, ###P < 0.001 vs. control group. In the 
histogram: dark grey = control, black = NaT, and white = NaT with C1.
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3.4. C1 reduced local and systemic complications in experimental AP 
models  
Oral gavage C1 was not as effective as intraperitoneal injections in the CER-
AP, thus the latter approach was used throughout in vivo studies. The effects 
of C1 on CER-AP and NaT-AP are shown in Figures 4 and 5, respectively. 
Hyperstimulation and retrospective pancreatic duct perfusion of NaT all caused 
typical histopathological features of AP - marked oedema, inflammatory cell 
infiltration and acinar cell necrosis (Huang et al., 2014; Huang et al., 2017a; 
Huang et al., 2017b; Mukherjee et al., 2016; Wen et al., 2015; Zhang et al., 
2016); these changes were also reflected by a dramatic increase of serum 
amylase and lipase, parameters to diagnose AP in clinical settings (Banks et 
al., 2013); pancreatic trypsin (not assessed in the NaT-AP) and MPO activities 
were increased which represented intrapancreatic digestive enzyme activation 
(Dawra et al., 2011) and neutrophil infiltration (Dawra et al., 2008), respectively; 
lung MPO and serum IL-6 levels were characteristics of systemic inflammation 
which were consistently elevated in both models employed. 
In the CER-AP, C1 at a lower dose (12.5 mg/kg) greatly improved pancreatic 
morphology (Figure 4A(i)) and halved the overall histopathological score 
(Figure 4A(ii)) with profound effects on reducing inflammatory cell infiltration 
(Figure 4A(iv)) and necrosis (Figure 4A(v)), but not oedema (Figure 4A(iii)). 
Similarly, C1 significantly reduced serum amylase (Figure 4B) and lipase 
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(Figure 4C), pancreatic trypsin (Figure 4D) and MPO (Figure 4E). In 
accordance with local injury, systemic injury markers lung MPO (Figure 4F) and 
serum IL-6 (Figure 4G) were also significantly decreased. The protective effects 
of C1 at higher doses (25 and 50 mg/kg) were inconsistent. 
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Fig. 4. Effects of C1 on severity of caerulein-induced acute pancreatitis (CER-
AP) in mice. CER-AP was induced by 7 intraperitoneal injections of caerulein 
(Cer) at hourly interval, while control mice received saline injections. In the 
treatment group, mice received intraperitoneal injections of C1 (12.5, 25 and 50 
mg/kg) at 0, 4 and 8 hours from the first injection of caerulein. All mice were 
sacrificed at 12 hours after first caerulein/saline injection. (A) C1 reduced 
pancreatic histopathology damage: (i) representative haematoxylin and eosin 
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(H&E) sections of pancreas from control, Cer and Cer with C1. (ii) overall 
histopathology score and its breakdown scores - (iii) oedema, (iv) inflammation 
and (v) necrosis. (B) Serum amylase. (C) Serum lipase. (D) Pancreatic trypsin 
activity. (E) Pancreatic myeloperoxidase (MPO) activity. (F) Lung MPO activity 
and (G) serum interleukin-6 (IL-6) levels. Data are expressed as means ± SEM 
from 6 or more animals per each group. *P < 0.05 and **P < 0.01 vs. Cer group, 
##P < 0.01 and ###P < 0.001 vs. control group. In the histogram: dark grey = 
control, black = Cer, and white = Cer with C1 at different doses.
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Informed by CER-AP, we used a lower concentration of C1 in the TLCS-AP 
(12.5 mg/kg) and NaT-AP (8.7 mg/kg; equivalent to 12.5 mg/kg in mice). C1 
significantly reduced overall histopathological score and breakdown scores as 
well as serum amylase and lipase (Supplementary Figure S-9A-9C). In 
agreement with these findings, C1 consistently improved pancreatic 
morphology (Figure 5A(i)), significantly reduced overall histopathological score 
(Figure 5A(ii)) and its breakdown scores: oedema (Figure 5A(iii)), inflammation 
score (Figure 5A(iv)) and necrosis (Figure 5A(v)). Serum amylase (Figure 5B) 
and lipase (Figure 5C), pancreatic MPO (Figure 5D), lung MPO (Figure 5E) and 
serum IL-6 (Figure 5F) were also invariably decreased. 
All the data obtained from in vivo studies suggest that C1 from the C. tinctoria 
has therapeutic potential for human AP and it is valuable to understand its 
mechanisms.  
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Fig. 5. Effects of C1 on severity of bile acid-induced acute pancreatitis (NaT-
AP) in rats. NaT-AP was induced by retrograde infusion of 3.5% taurocholic 
acid sodium salt hydrate into the pancreatic duct, while control rats received 
sham operation. In the treatment group, rats received intraperitoneal injections 
of C1 (8.7 mg/kg; equivalent to 12.5 mg/kg in mice) at 0, 4 and 8 hours post-
operation. All rats were sacrificed at 24 hours post-operation. (A) C1 reduced 
pancreatic histopathology damage: (i) representative haematoxylin and eosin 
(H&E) sections of pancreas from control, NaT, and NaT with C1. (ii) overall 
histopathology score and its breakdown scores - (iii) oedema, (iv) inflammation 
and (v) necrosis. (B) Serum amylase. (C) Serum lipase. (D) Pancreatic 
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myeloperoxidase (MPO) activity. (E) Lung MPO activity and (F) serum 
interleukin-6 (IL-6) levels. Data are expressed as means ± SEM from 6 or more 
animals per each group. *P < 0.05 and **P < 0.01 vs. NaT group, #P < 0.05, ##P 
< 0.01 and ###P < 0.001 vs. control group. In the histogram: dark grey = control, 
black = NaT, and white = NaT with C1.
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3.5. C1 up-regulated pancreatic Nrf2 protein 
Since C. tinctoria is well known for its antioxidant effects (Chen et al., 2016; 
Dias et al., 2010), we hypothesised that the protective effects offered by C1 
were at least operating in part through this mechanism. Moreover, Nrf2/ARE-
mediated antioxidant signalling pathway represents one of the most important 
cellular defence mechanisms against oxidative stress, and we examined the 
levels of pancreatic Nrf2 and NF-κB p65 protein expression, and Nrf2 targeted 
stress response protein HO-1 and antioxidant enzymes (GPx and SOD). 
Representative IHC images of Nrf2 staining are shown in Figure 6A. There was 
scattered staining in the cytosol but no discernible staining in the nucleus of 
saline controls; marked staining in both cytosol and nucleus was observed in 
the caerulein treated group; C1 at all doses increased the overall expression of 
Nrf2 protein with most marked effect achieved by 12.5 mg/kg. To further confirm 
these findings, Western-blot analysis of Nrf2 protein from the pancreatic tissue 
lysate was conducted. Representative Western-blot images of Nrf2 protein are 
displayed in Figure 6B. The trend of Nrf2 protein expression was in line with the 
IHC findings. Quantitative Western-blot analysis revealed that the Nrf2 protein 
in the caerulein group was significantly higher, compared with the saline group, 
while C1 treated groups were even higher with only the low dose group (12.5 
mg/kg) reaching statistical significance compared with caerulein (Figure 6C). 
The findings of pancreatic Nrf2 protein expression were mirrored by the NF-κB 
p65 (Figure 6D). It is shown that caerulein administration increased pancreatic 
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NF-κB p65 compared with saline injections, while C1 treatment reduced 
caerulein-induced NF-κB p65 activation (Figure 6E). However, no statistical 
significance was reached between groups of designated comparison.  
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Fig. 6. Effects of C1 on pancreatic Nrf2 and NF-κB (p65) expressions in 
caerulein-induced acute pancreatitis (CER-AP) in mice. CER-AP was induced 
by 7 intraperitoneal injections of caerulein (Cer) at hourly interval, while control 
mice received saline injections. In the treatment group, mice received 
intraperitoneal injections of C1 (12.5, 25 and 50 mg/kg) at 0, 4 and 8 hours from 
the first injection of caerulein. All mice were sacrificed at 12 hours after first 
caerulein/saline injection. Pancreatic tissues were homogenised for 
immunohistochemistry and Western-blot analysis of Nrf2 and NF-κB p65 
protein expression. (A) Representative immunohistochemistry images from 
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control, Cer, and Cer with C1 (red arrow indicates Nrf2 nuclear translocation). 
(B) Representative Western-blot images for Nrf2 from control, Cer, and Cer with 
C1. (C) Quantification of Western-blot images for Nrf2. (D) Representative 
Western-blot images for NF-κB p65 from control, Cer, and Cer with C1. (E) 
Quantification of Western-blot images for NF-κB p65. Data are expressed as 
means ± SEM from 4 or more animals per each group.**P< 0.01 vs. Cer group, 
##P < 0.01 vs. control group. In the histogram: dark grey = control, black = Cer, 
and white = Cer with C1 at different doses.
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3.6. C1 increased the pancreatic Nrf2-targeted stress response protein 
HO-1 and antioxidant enzymes GPx and SOD
The IHC and Western-blots images as well as Western-blot quantification of 
HO-1 protein expression are shown in Figure 7A, B and C, respectively. These 
data are in agreement with the Nrf2 protein expression profile that the HO-1 
protein expression was: C1 (12.5 mg/kg) treated > caerulein alone > saline 
controls. 
Consistent with published literature (Leung and Chan, 2009), the pancreatic 
antioxidant enzymes GPx (Figure 7D) and SOD (Figure 7E) were significantly 
reduced after caerulein challenge. In accord with C1 activation of the Nrf2/ARE 
antioxidant signalling pathways, C1 at low to moderate doses (12.5 and 25 
mg/kg) increased pancreatic GPx (Figure 7D) and SOD (Figure 7E) levels, 
albeit a statistical significance was not reached by C1 at 12.5 mg/kg for SOD. 
However, C1 at 50 mg/kg was ineffective. 
These data of C1 on pancreatic Nrf2, HO-1, GPx and SOD collectively suggest 
that C1 may reduce severity of AP by promoting pancreatic antioxidant enzyme 
generation via activation of Nrf2/ARE pathways. 
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Fig. 7. Effects of C1 on pancreatic Nrf2/ARE-mediated signalling pathways in 
caerulein-induced acute pancreatitis (CER-AP) in mice. CER-AP was induced 
by 7 intraperitoneal injections of caerulein (Cer) at hourly interval, while control 
mice received saline injections. In the treatment group, mice received 
intraperitoneal injections of C1 (12.5, 25 and 50 mg/kg) at 0, 4 and 8 hours from 
the first injection of caerulein. All mice were sacrificed at 12 hours after first 
caerulein/saline injection. Pancreatic tissues were homogenised for 
immunohistochemistry and Western-blot analysis of HO-1 protein expression 
as well as to test GPx and SOD levels. (A) Representative 
immunohistochemistry images from control, Cer, and Cer with C1 for HO-1. (B) 
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Representative Western-blot images from control, Cer and Cer with C1. (C) 
Quantification of Western-blot images for HO-1. (D) GPx and (E) SOD. Data 
are expressed as means ± SEM from 4 or more animals per each group. *P < 
0.05 vs. Cer group, ##P < 0.01 vs. control group. In the histogram: dark grey = 
control, black = Cer, and white = Cer with C1 at different doses.
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4. Discussion
In this study, we successfully used LC-MS to isolate targeted flavonoids from 
C. tinctoria, a well-known flower tea material having antioxidant properties that 
is used world-wide (Chen et al., 2016). For the first time we tested these 
flavonoids on necrotic cell death pathway activation induced by NaT in acinar 
cells and identified that C1 had the best protective effects. Further C1 was 
shown to reduce ROS production and prevent ATP depletion in acinar cells. 
Moreover, using the most widely used (hyperstimulation) and clinical aetiology 
relevant (bile acid) models, we have shown that C1 markedly reduced the 
severity of AP, evidenced by suppressed histopathological, biochemical and 
immunological parameters for local and systemic complications. Lastly, we 
found that the pancreatic Nrf2, HO-1, GPx and SOD levels were significantly 
increased by C1 treatment when compared to caerulein challenge alone, 
suggesting a Nrf2/ARE-mediated antioxidant signalling pathway activation in 
protecting against AP.  
Several in vivo studies found that natural compounds ameliorate oxidative 
stress and therefore have therapeutic potential for a various of conditions 
including inflammatory diseases like AP (Anchi et al., 2017; Shapiro et al., 
2007). C. tinctoria has been well-known for its antioxidant capacity (Chen et al., 
2016; Dias et al., 2010) but there are no studies assessing its effects on AP, a 
disease in which oxidative stress plays an important role in the pathogenesis 
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(Booth et al., 2011a; Hackert and Werner, 2011; Leung and Chan, 2009). 
Phytochemical and pharmacological studies have shown that flavonoids (Chen 
et al., 2016; Dias et al., 2010) and polyacetylene glycosides (Du et al., 2016; 
Guo et al., 2017) are the main biological components of C. tinctoria. A few 
dozens of papers have indicated that the flavonoids-rich fraction could increase 
insulin sensitivity, regulate hepatic metabolism, promote glucose tolerance 
regain, and protect from liver injury due to the antioxidant activity of flavonoids 
(Dias et al., 2010; Dias et al., 2012; Jiang et al., 2015; Tsai et al., 2017). 
Therefore, in this study we isolated targeted flavonoids from C. tinctoria and 
tested their effects towards AP. 
In vitro pancreatic acinar cell necrosis model induced by NaT was first used to 
identify the best protective activity from TFE and flavonoids 1-6 (C1-C6) 
isolated from C. tinctoria. A previous study used 0.4 mM of marein and 
flavanomarein and showed that these flavonoids attenuated tert-butyl 
hydroperoxide-induced beta-pancreatic MIN6 cell death in vitro (Dias et al., 
2012). Hence, we started to test the extracted TFE and flavonoids on freshly 
isolated acinar cells using 1 mM with or without application of NaT. All 
flavonoids had no effects on cell death per se, while C1-C4 significant reduced 
NaT-induced necrotic cell death pathway activation with C1 exhibiting the most 
pronounced protective effects. However, C5 and C6 with a pair of naturally and 
easily inter-convertible isomers, did not significantly protected against 
pancreatic acinar necrosis at 1 mM. According to the structure-activity 
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relationship analysis, the protective activities order of isolates C1-C6 are: 
flavanonol > flavanone > chalcone > nurone. Further dose characterisation of 
C1 demonstrated that it reached a maximal inhibitory effect at 0.5 mM among 
the doses tested. It is known that the bile acid TLCS induced increased ROS 
production, and excessive ROS was associated with mitochondrial membrane 
potential depolarisation and ATP depletion (Booth et al., 2011a). In our previous 
study (Zhang et al., 2016), we have also shown that NaT, the most commonly 
used bile acid in literature to induce AP (Lerch and Gorelick, 2013; Wan et al., 
2012), also caused ROS production, mitochondrial membrane potential 
depolarisation, ATP depletion and necrotic cell death pathway activation in 
freshly isolated acinar cells. Flavonoids are regarded as free radical scavengers 
by donating hydrogen ions to neutralise toxic ROS. (Ma et al., 2016) Thus, 0.5 
mM of C1 was used to evaluate its effect on ROS generation and ATP depletion 
induced by NaT in acinar cells. Consequently, C1 prevented excessive ROS 
production and ATP depletion. Our in vitro data are consistent with the 
protective effects of (2R,3R)-taxifolin 7-O-β-D-glucopyranoside (C1) on 
preventing necrotic cell death pathway activation to result from the reduction of 
oxidative stress. We have not excluded any contribution of C1 to protection 
through any other mechanism that might simultaneously alleviate oxidative 
stress. Nevertheless the increase of Nrf2 and HO-1 expression with NaT and 
C1 over both negative (no NaT) and positive (NaT without C1) control 
conditions supports a role for Nrf2.
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To demonstrate the protective effects of C1 on AP injury in vivo, we used a 
regimen of C1 intraperitoneal administration at 0, 4 and 8 hours from first 
caerulein injection or post-surgery. Firstly, compared with oral gavage, 
intraperitoneal injection of C1 showed better effects to reduce histopathological, 
biochemical and immunological changes. The injection time interval was 
referred to pharmacokinetic parameters of C1 analogue and our previous 
treatment (Khaled et al., 2003; Yang et al., 2016; Zhang et al., 2016). Normally 
the half-life of flavonoids and their glycosides are within 2 hours after 
intravenous injection and within 4 hours after oral dose, thus a 4-hour interval 
could maintain a reasonable blood concentration of flavonoid metabolites. 
Lastly, the three doses of 12.5, 25 and 50 mg/kg were chosen according to 
former studies which indicated that the C1 analogue quercetin ameliorates AP 
at 25, 50 and 100 mg/kg at the tested oral doses 1 hour before induction and 
at 100, 150 and 200 mg/kg by intraperitoneal injection (Carvalho et al., 2010; 
Zheng et al., 2016). 
The summary in vivo findings suggest that C1 at a lower dose (12.5 mg/kg) 
consistently reduced all the parameters of disease severity, paving the way for 
further in-depth characterisation of this natural compound as clinically there is 
no licensed medicine for treating human AP (Moggia et al., 2017). Although 
clinical trials of anti-oxidants have as yet failed to deliver a licensed therapy 
(Hackert et al., 2011), the wrong anti-oxidant treatment may have been trialled 
and/or started too late during the course of AP. Pre-existing DM acerbates the 
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severity of AP and AP is associated with substantial occurrence of prediabetic 
and/or DM (Das et al., 2014); C1 might be used to target AP and DM 
simultaneously. Furthermore, emerging experimental evidence suggests that 
insulin protects against pancreatic toxin-induced acinar cell injury by 
ameliorating pathological calcium signalling, independent of oxidative stress 
(Mankad et al., 2012; Samad et al., 2014). Since oxidative stress is implicated 
in DM (Johansen et al., 2005; Maritim et al., 2003), and C1 counteracts both 
DM and AP, further studies are warranted to investigate the effects of C1 on 
the onset of AP with pre-existing DM and onset of DM after AP. Further work is 
also required to understand the loss of effect at higher doses of C1, potentially 
due to interference with redox signalling essential to mitochondrial metabolism 
(Booth et al., 2011a, 2011b).
Since most of the protective effective of flavonoids are attributed to its 
antioxidant properties and Nrf2 is one of the most important factors to regulate 
this, we questioned that C1 protected against AP via up-regulating Nrf2/ARE. 
Recently, strategies of up-regulating Nrf2 in both pancreas and lung by natural 
or synthetic compounds have been shown to reduce the severity of AP (Dong 
et al., 2016; Jung et al., 2010; Robles et al., 2016; Wang et al., 2014). A variety 
of small molecule inducers of Nrf2 have been identified from natural sources as 
well as from synthetic agents. The chemical structures of inducers include 
Michael acceptors, oxidisable diphenols, isothiocyanates and etc. (Magesh et 
al., 2012). Up till now, only one study reported that the Nrf2 inducer 
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sulforaphane, a natural isothiocyanate, attenuated pancreatic damage by 
exerting antioxidant defensive activities through the Nrf2 pathway (Dong et al., 
2016). Among the isolates C1-C6, C3 has been used as Nrf2 activator, which 
was able to stabilise Nrf2 by delaying Nrf2 degradation (Hu et al., 2012). In our 
study, C1 treatment induced pancreatic Nrf2 activation and its nuclear 
translocation in CER-AP, which resulted in significantly elevated HO-1, GPx 
and SOD compared to CER-AP alone. Interestingly, in contrary to the previous 
study using CER-AP (Dong et al., 2016), we observed increased cytosolic and 
nuclear expression of Nrf2 rather than reduced when compared to the saline 
controls. The reason for this may due to the different time of assessing Nrf2 
protein expression. The previous study tested the Nrf2 expression one hour 
after last injection of caerulein, while we did this a few hours later. It may well 
be that immediately after caerulein injection the antioxidant capacity was more 
suppressed since the stimuli still existed. It is worthwhile to conduct 
experiments to dynamically measure the expression of Nrf2 and Nrf2/ARE-
dependent antioxidant enzymes in AP models to understand their changes 
according to the disease course.
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5. Conclusions 
The present study, for the first time, has demonstrated protective effects of 
flavonoids isolated from C. tinctoria against AP injury. It is likely that C1, the 
most effective compound, protected against AP both in vitro and in vivo by its 
antioxidant property, at least in part via up-regulating Nrf2 and thus the 
Nrf2/ARE-associated antioxidant enzymes. The results suggest the potential 
utilisation of C. tinctoria to protect pancreatic disorders like AP.
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Figure S-1. Procedure of isolating total flavonoid extract and compounds 1-6. 
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Figure S-8. Effects of total extract (TE) and components of C. tinctoria after 
first isolation using polyamide (CP) on necrotic cell death activation in mouse 
pancreatic acinar cells. Cells were treated with normal saline or taurocholic acid 
sodium salt hydrate (NaT, 5 mM) with or without extractions at designated 
concentrations. The necrosis % (PI uptake) induced by NaT was calculated 
from Hoechst 33342 stained cells and multiply by 100 %. Effects of TE and CP 
were assessed at the concentration of 1 mM. Data are expressed as mean ± 
SEM from 3 or more independent experiments. *P < 0.05 vs. model group, #P 
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< 0.001 vs. control group. In the histogram: dark grey = control, black = NaT, 
and white = NaT with TE or CP. (Page 60)
Figure S-9. Effects of C1 on severity of bile acid-induced acute pancreatitis 
(TLCS-AP) in mice. TLCS-AP was induced by retrograde infusion of 3.5% 
taurolithocholic acid 3-sulfate disodium salt into the pancreatic duct, while 
control mice received sham operation. In the treatment group, rats received 
intraperitoneal injections of C1 (12.5 mg/kg) at 0, 4 and 8 hours post-operation. 
All mice were sacrificed at 24 hours post-operation. (A) C1 reduced pancreatic 
histopathology damage: (i) representative haematoxylin and eosin (H&E) 
sections of pancreas from control, TLCS, and TLCS with C1. (ii) overall 
histopathology score and its breakdown scores - (iii) oedema, (iv) inflammation 
and (v) necrosis. (B) Serum amylase. (C) Serum lipase. Data are expressed as 
means ± SEM from 5 or more animals per each group. *P < 0.05 vs. TLCS 
group, #P < 0.001 vs. control group. In the histogram: dark grey = control, black 
= TLCS, and white = TLCS with C1. (Page 61)
52
Table S-1 Flavonoids identified from the total flavonoids extract based on its 
LC-MS BPI chromatography
NO. Component 
name
Formula R
T
Observed 
m/z
Mass 
error 
(mDa)
Detector 
counts
Adducts
1 Dihydroquercetin 
7-O-glucoside
C21H22O12 3.22 465.1031 -0.71 341995 -H
2 Dihydroquercetin 
7-O-glucoside
C21H22O12 3.48 465.1026 -1.23 40018 -H
3 Flavanomarein C21H22O11 3.93 449.1076 -1.31 2119268 -H
4 6-hydroxy 
kaempferol 7-O-
glucoside
C21H20O12 4.12 463.0870 -1.15 76063 -H
5 4’,5,7-trihydroxy-
flavone 3-O-
glucoside
C21H22O10 4.14 433.1128 -1.26 345186 -H
6 Quercetagetin 7-
O-glucoside
C21H20O13 4.28 479.0815 -1.65 1190623 -H, 
+HCOO
7 3,5,7,4’-
tetrahydroxy 
flavanone
C15H12O6 4.68 287.0556 -0.56 837951 -H
8 Marein isomer C21H22O11 4.80 449.1079 -1.08 1072511 -H
9 Maritimein C21H20O11 4.80 447.0925 -0.81 726802 -H, 
+HCOO
10 Hyperin C21H20O12 4.85 463.0875 -0.71 365908 -H
11 Marein C21H22O11 4.90 449.1078 -1.18 3891522 -H
12 Luteolin 7-O-
glucoside
C21H20O11 4.95 447.0923 -0.94 117442 -H
13 Marigold 
glucoside
C22H22O13 5.00 493.0974 -1.40 156799 -H, 
+HCOO
14 7-O-glucosyl-
kaempferol
C21H20O11 5.43 447.0922 -1.06 38977 -H
15 Coreopsin C21H22O10 5.52 433.1128 -1.25 1539334 -H
16 8-hydroxy fustin C15H12O6 5.97 287.0553 -0.79 531429 -H
17 Okanin C15H12O6 6.49 287.0546 -1.49 20769 -H
18 Quercetin C15H10O7 6.69 301.0345 -0.92 38318 -H
19 7,3’,5’-trihydroxy 
flavanone
C15H12O5 7.32 271.0602 -0.99 28096 -H
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